Analyst Consensus ?
ConsensusHold29 ratings
Bullish1448.3%
Neutral1551.7%
Bearish00.0%
FN2 Earnings Intelligence
IDEX Corporation complete analyst coverage
IDEX Corporation (IEX) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$233.77Previous close
$180Low
$235Average
$268High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Jul 31, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| TD Cowen | Buy | Buy | Maintain | Jul 30, 2026 |
| Stifel | Buy | Buy | Maintain | Jul 30, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 30, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 30, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Jul 21, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Mar 27, 2026 |
| Argus Research | Buy | Hold | Upgrade | Feb 6, 2026 |
| DA Davidson | Neutral | Neutral | Maintain | Feb 5, 2026 |
| Baird | Outperform | Outperform | Maintain | Oct 31, 2024 |
| Wells Fargo | Overweight | Overweight | Maintain | Apr 28, 2023 |
| Mizuho | Neutral | Neutral | Maintain | Apr 28, 2023 |
| Bernstein | Market Perform | Market Perform | Maintain | Apr 28, 2023 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jan 18, 2023 |
| Loop Capital | Hold | Hold | Maintain | Jul 19, 2022 |
| Cowen & Co. | Outperform | Market Perform | Upgrade | Mar 9, 2022 |
| Rosenblatt | Buy | Buy | Maintain | May 3, 2021 |
| Janney Montgomery Scott | Neutral | Buy | Downgrade | Apr 8, 2020 |
| Janney Capital | Neutral | Buy | Downgrade | Apr 8, 2020 |
| Stifel Nicolaus | Hold | Hold | Maintain | Jul 29, 2019 |
| Berenberg | Buy | Buy | Maintain | May 15, 2019 |
| UBS | Neutral | Neutral | Maintain | Jan 23, 2018 |
| KeyBanc | Equal Weight | Sector Weight | Maintain | May 23, 2016 |
| SunTrust Robinson Humphrey | Neutral | Neutral | Maintain | Nov 3, 2015 |
| Jefferies | Hold | Hold | Maintain | Jun 12, 2015 |
| Brean Capital | Buy | Hold | Upgrade | Jan 30, 2014 |
| Longbow Research | Neutral | Neutral | Maintain | Oct 1, 2013 |
| BB&T Capital | Hold | Hold | Maintain | Mar 15, 2013 |
| CL King | Neutral | Buy | Downgrade | Dec 12, 2012 |
| Barrington Research | Outperform | Outperform | Maintain | Jul 24, 2012 |
Named analyst price targets
Upside is calculated against the persisted previous close $233.77. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Oppenheimer | Analyst unavailable | $265 | $236.82 | +13.4% | Jul 30, 2026 |
| Stifel Nicolaus | Nathan Jones | $268 | $229.52 | +14.6% | Jul 30, 2026 |
| Stifel Nicolaus | Nathan Jones | $257 | $224.94 | +9.9% | Jul 20, 2026 |
| RBC Capital | Analyst unavailable | $261 | $227.6 | +11.6% | Jul 16, 2026 |
| Oppenheimer | Analyst unavailable | $250 | $207.59 | +6.9% | Jun 2, 2026 |
| Seaport Global | Walt Liptak | $250 | $215.78 | +6.9% | May 5, 2026 |
| RBC Capital | Analyst unavailable | $252 | $217.93 | +7.8% | Apr 30, 2026 |
| Stifel Nicolaus | Analyst unavailable | $250 | $217.68 | +6.9% | Apr 30, 2026 |
| Oppenheimer | Analyst unavailable | $242 | $217.34 | +3.5% | Apr 30, 2026 |
| Robert W. Baird | Analyst unavailable | $257 | $217.34 | +9.9% | Apr 30, 2026 |
| Stifel Nicolaus | Analyst unavailable | $241 | $205.12 | +3.1% | Apr 14, 2026 |
| BMO Capital | Analyst unavailable | $214 | $189.73 | -8.5% | Mar 26, 2026 |
| Seaport Global | Analyst unavailable | $240 | $212.26 | +2.7% | Feb 9, 2026 |
| Argus Research | Analyst unavailable | $240 | $212.94 | +2.7% | Feb 6, 2026 |
| RBC Capital | Analyst unavailable | $244 | $211.02 | +4.4% | Feb 5, 2026 |
| Oppenheimer | Bryan Blair | $230 | $209.86 | -1.6% | Feb 5, 2026 |
| Robert W. Baird | Michael Halloran | $247 | $212.25 | +5.7% | Feb 5, 2026 |
| Stifel Nicolaus | Analyst unavailable | $220 | $196.43 | -5.9% | Jan 23, 2026 |
| RBC Capital | Analyst unavailable | $211 | $194.99 | -9.7% | Jan 15, 2026 |
| RBC Capital | Analyst unavailable | $195 | $175.97 | -16.6% | Oct 30, 2025 |
| Stifel Nicolaus | Analyst unavailable | $191 | $167.51 | -18.3% | Oct 20, 2025 |
| Oppenheimer | Analyst unavailable | $210 | $167.05 | -10.2% | Oct 7, 2025 |
| D.A. Davidson | Analyst unavailable | $180 | $158.25 | -23.0% | Aug 4, 2025 |
| Mizuho Securities | Brett Linzey | $185 | $190.85 | -20.9% | May 16, 2025 |
| Robert W. Baird | Michael Halloran | $215 | $181.45 | -8.0% | May 2, 2025 |
| Mizuho Securities | Brett Linzey | $175 | $166.4 | -25.1% | Apr 22, 2025 |
| RBC Capital | Deane Dray | $248 | $218.64 | +6.1% | Oct 31, 2024 |
| D.A. Davidson | Matt Summerville | $210 | $194.12 | -10.2% | Aug 5, 2024 |
| Oppenheimer | Bryan Blair | $238 | $192.75 | +1.8% | Aug 5, 2024 |
| Robert W. Baird | Michael Halloran | $256 | $224.64 | +9.5% | Apr 25, 2024 |
| Stifel Nicolaus | Nathan Jones | $265 | $225.83 | +13.4% | Feb 8, 2024 |
| Stifel Nicolaus | Nathan Jones | $188 | $186.26 | -19.6% | Jul 18, 2022 |
| RBC Capital | Deane Dray | $238 | $188.06 | +1.8% | May 9, 2022 |
| Citigroup | Analyst unavailable | $235 | $191.15 | +0.5% | Apr 28, 2022 |
| Mizuho Securities | Analyst unavailable | $205 | $191.42 | -12.3% | Apr 28, 2022 |
| Bernstein | Brendan Luecke | $230 | $224.3 | -1.6% | Jan 10, 2022 |
| D.A. Davidson | Matt Summerville | $220 | $222.43 | -5.9% | Oct 28, 2021 |
| Morgan Stanley | Connor Lynagh | $250 | $225.91 | +6.9% | Apr 29, 2021 |
Track every rating change on IEX the moment it posts. Free to start.
Start free